While it has been established that the pharmacokinetics (PK) of daptomycin in children are age-dependent 6, only scarce data exist on the extent of penetration of daptomycin into the inflamed CSF. Anecdotal evidence indicates that in humans with inflamed meninges daptomycin penetrates into the CSF in sufficient amounts. This is supported by animal studies.